1. Home
  2. PWR vs MDT Comparison

PWR vs MDT Comparison

Compare PWR & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PWR

Quanta Services Inc.

HOLD

Current Price

$718.37

Market Cap

106.2B

Sector

Industrials

ML Signal

HOLD

Logo Medtronic plc.

MDT

Medtronic plc.

HOLD

Current Price

$78.12

Market Cap

105.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PWR
MDT
Founded
1997
1949
Country
United States
Ireland
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
106.2B
105.3B
IPO Year
1997
2014

Fundamental Metrics

Financial Performance
Metric
PWR
MDT
Price
$718.37
$78.12
Analyst Decision
Buy
Buy
Analyst Count
21
21
Target Price
$564.40
$108.21
AVG Volume (30 Days)
975.3K
10.4M
Earning Date
04-30-2026
06-03-2026
Dividend Yield
0.07%
3.58%
EPS Growth
12.77
30.80
EPS
1.45
2.76
Revenue
$28,479,697,000.00
$33,537,000,000.00
Revenue This Year
$18.56
$8.91
Revenue Next Year
$12.72
$6.54
P/E Ratio
$497.30
$29.45
Revenue Growth
20.31
3.62
52 Week Low
$358.38
$73.31
52 Week High
$788.75
$106.33

Technical Indicators

Market Signals
Indicator
PWR
MDT
Relative Strength Index (RSI) 53.00 45.98
Support Level $687.03 $73.85
Resistance Level $788.75 $79.25
Average True Range (ATR) 27.43 1.75
MACD -0.84 0.33
Stochastic Oscillator 77.22 50.58

Price Performance

Historical Comparison
PWR
MDT

About PWR Quanta Services Inc.

Quanta Services is a leading provider of specialty contracting services, delivering comprehensive infrastructure solutions for the electric and gas utility, communications, pipeline, and energy industries in the United States, Canada, and Australia. Quanta reports its results under two segments: electric and underground utility and infrastructure.

About MDT Medtronic plc.

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.

Share on Social Networks: